173 related articles for article (PubMed ID: 37133830)
1. Addiction Medicine Physicians and Medicinal Cannabinoids.
Potenza MN; Bunt G; Khalsa JH
JAMA Psychiatry; 2023 Jul; 80(7):659-660. PubMed ID: 37133830
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
Baron EP
Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
[TBL] [Abstract][Full Text] [Related]
3. Medicinal cannabis: moving the debate forward.
Newton-Howes G; McBride S
N Z Med J; 2016 Nov; 129(1445):103-109. PubMed ID: 27857243
[TBL] [Abstract][Full Text] [Related]
4. Medicinal use of cannabis based products and cannabinoids.
Freeman TP; Hindocha C; Green SF; Bloomfield MAP
BMJ; 2019 Apr; 365():l1141. PubMed ID: 30948383
[No Abstract] [Full Text] [Related]
5. Cannabis and Cannabinoids for Chronic Pain.
Romero-Sandoval EA; Kolano AL; Alvarado-Vázquez PA
Curr Rheumatol Rep; 2017 Oct; 19(11):67. PubMed ID: 28983880
[TBL] [Abstract][Full Text] [Related]
6. Time to acknowledge the mixed effects of cannabis on health: a summary and critical review of the NASEM 2017 report on the health effects of cannabis and cannabinoids.
Cousijn J; Núñez AE; Filbey FM
Addiction; 2018 May; 113(5):958-966. PubMed ID: 29271031
[TBL] [Abstract][Full Text] [Related]
7. Understanding Cannabis-Based Therapeutics in Sports Medicine.
Maurer GE; Mathews NM; Schleich KT; Slayman TG; Marcussen BL
Sports Health; 2020; 12(6):540-546. PubMed ID: 32936058
[TBL] [Abstract][Full Text] [Related]
8. Re-branding cannabis: the next generation of chronic pain medicine?
Carter GT; Javaher SP; Nguyen MH; Garret S; Carlini BH
Pain Manag; 2015; 5(1):13-21. PubMed ID: 25537695
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids: for better and for worse
.
Thibaut F; Hoehe MR
Dialogues Clin Neurosci; 2020 Sep; 22(3):201-204. PubMed ID: 33162763
[TBL] [Abstract][Full Text] [Related]
10. Contemporary Routes of Cannabis Consumption: A Primer for Clinicians.
Peters J; Chien J
J Am Osteopath Assoc; 2018 Feb; 118(2):67-70. PubMed ID: 29379971
[TBL] [Abstract][Full Text] [Related]
11. Medicinal cannabis pharmacokinetics and potential methods of delivery.
Kebede L; Masoomi Dezfooli S; Seyfoddin A
Pharm Dev Technol; 2022 Feb; 27(2):202-214. PubMed ID: 35084279
[TBL] [Abstract][Full Text] [Related]
12. Introduction to special issue: Therapeutic and abuse-related effects of cannabis and cannabinoids.
Acheson A; Fantegrossi WE
Exp Clin Psychopharmacol; 2019 Aug; 27(4):299-300. PubMed ID: 31355665
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids: Friend or foe?
Le Foll B; Tyndale RF
Clin Pharmacol Ther; 2015 Jun; 97(6):528-31. PubMed ID: 25801347
[TBL] [Abstract][Full Text] [Related]
14. Positive and Negative Effects of Cannabis and Cannabinoids on Health.
Cohen K; Weizman A; Weinstein A
Clin Pharmacol Ther; 2019 May; 105(5):1139-1147. PubMed ID: 30703255
[TBL] [Abstract][Full Text] [Related]
15. Medicinal cannabis and painful sensory neuropathy.
Grant I
Virtual Mentor; 2013 May; 15(5):466-9. PubMed ID: 23680571
[No Abstract] [Full Text] [Related]
16. Clinical uses of cannabis and cannabinoids in the United States.
Levinsohn EA; Hill KP
J Neurol Sci; 2020 Apr; 411():116717. PubMed ID: 32044684
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids for the Treatment of Opioid Use Disorder: Where is the Evidence?
Suzuki J; Weiss RD
J Addict Med; 2021 Apr; 15(2):91-92. PubMed ID: 32909980
[TBL] [Abstract][Full Text] [Related]
18. Medical cannabis and cannabinoids in rheumatology: where are we now?
Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
[No Abstract] [Full Text] [Related]
19. Marijuana Use in Epilepsy: The Myth and the Reality.
Detyniecki K; Hirsch L
Curr Neurol Neurosci Rep; 2015 Oct; 15(10):65. PubMed ID: 26299273
[TBL] [Abstract][Full Text] [Related]
20. The Cannabis Spread throughout the Continents and its Therapeutic Use in History.
Charitos IA; Gagliano-Candela R; Santacroce L; Bottalico L
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):407-417. PubMed ID: 32433013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
